MedCity News Sponsored Webinar

Accelerate time to target endpoint in Cardiometabolic studies using patient-centered technology solutions

Date: June 9, 2022

Time: 11am ET / 8am PT

It’s no secret that our industry’s cardiometabolic pipeline has slowed, as the time and cost of evidence needed to generate regulatory approval continues to grow. 

For many cardiometabolic trials, time and cost factors are often a result of slow enrollment, lengthy trial duration, intensive trial-related testing, and delays in signal detection. 

Learn how to combat these, and more, with this free webinar featuring industry experts from Syneos and Medable. Together, they’ll share how to address these challenges, while also identifying how trials will change as a result of new regulatory guidance such as the DEPICT Act.

They’ll also identify how to use technology and home health solutions to augment existing points of care between patients and their clinical care team to improve the patient experience, drive more scientific rigor to data generation and achieve timely endpoint capture. 

Key learning objectives for this webinar include:

  • Best practices in the use of digital and home health solutions to solve key delivery pain points in cardiometabolic trials (including wearables/sensors/connected devices)
  • How to leverage technology to achieve better patient representation in trials to meet the requirement of new DEI regulatory guidance
  • How to accelerate time to target endpoint while improving the patient experience using best-in-class digital solutions

Who should attend:

  • Clinical operations / development professionals
  • Cardiometabolic TA lead professionals
  • R&D IT / technology professionals
  • Chief Diversity Officers (DEI related roles)
  • Chief Medical Officers / Chief Scientific Officers
  • Clinical trial strategy team professionals

Cardiometabolic Clinical Studies

Learn how to combat these, and more, with this free webinar featuring industry experts from Syneos and Medable. Together, they’ll share how to address these challenges, while also identifying how trials will change as a result of new regulatory guidance such as the DEPICT Act.
Our speakers:

Claire Marsden is a Vice President of DCT Solutions, CV/MET at Medable.

MaryAnne Rizk is a Chief Strategy Officer at Medable.

Tammy D'Lugin-Monroe is a Vice President, Global Head Therapeutic Strategy Innovation at Syneos Health.

Cardiometabolic Clinical Studies

Learn how to combat these, and more, with this free webinar featuring industry experts from Syneos and Medable. Together, they’ll share how to address these challenges, while also identifying how trials will change as a result of new regulatory guidance such as the DEPICT Act.
Our speakers:

Claire Marsden is a Vice President of DCT Solutions, CV/MET at Medable.

MaryAnne Rizk is a Chief Strategy Officer at Medable.

Tammy D'Lugin-Monroe is a Vice President, Global Head Therapeutic Strategy Innovation at Syneos Health.